BL1107 FIRST GLAUCOMA THERAPY TO IMPROVE VISUAL FUNCTION THROUGH NEUROPROTECTION ELIOS FIRST CLINICIALLY VALIDATED IMPLANT-FREE MIGS EXCIMER LASER Disclaimers Forward-Looking Statements This presentation contains forward-looking information and statements, within the meaning of applicable securities laws (collectively, "forward-looking statements"), including, but not limited to, statements our focus on pipeline innovation, the success of our pipeline products and R&D programs, the existence of potential ga ...